Factors affecting the response to Y-90 microsphere therapy in the cholangiocarcinoma patients
ConclusionsBoth resin and glass microsphere therapy can be applied safely to iCCA and eCCA patients. Early therapy response can be evaluated with both RECIST and PERCIST criteria. Both anatomical and metabolic therapy response evaluations give complementary information.
Source: La Radiologia Medica - Category: Radiology Source Type: research
More News: Bile Duct Cancer | Cholangiocarcinoma | Liver | Perfusion | Radiology | Statistics | Study | Urology & Nephrology